These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Structural analysis of NADH-cytochrome b5 reductase in relation to hereditary methemoglobinemia. Yubisui T; Murakami K; Shirabe K; Takeshita M; Zenno S; Tomatsu S; Fukumaki Y Prog Clin Biol Res; 1989; 319():107-19; discussion 120-1. PubMed ID: 2695933 [No Abstract] [Full Text] [Related]
4. [Cell differentiation, maturation and enzyme abnormality--studies on NADH-cytochrome b5 reductase]. Takeshita M; Yubisui T Rinsho Ketsueki; 1986 Jul; 27(7):1138-44. PubMed ID: 3783996 [No Abstract] [Full Text] [Related]
5. Engineering and characterization of a NADPH-utilizing cytochrome b5 reductase. Marohnic CC; Bewley MC; Barber MJ Biochemistry; 2003 Sep; 42(38):11170-82. PubMed ID: 14503867 [TBL] [Abstract][Full Text] [Related]
6. [Molecular analysis of the structure of the mutant NADH-cytochrome b5 reductase gene causing methemoglobinemia]. Kobayashi Y Fukuoka Igaku Zasshi; 1990 Jan; 81(1):41-7. PubMed ID: 2323714 [TBL] [Abstract][Full Text] [Related]
7. [Leu 72 Pro mutation in the NADH-cytochrome b5 reductase gene found in a Chinese hereditary methemoglobinemia patient]. Wu Y; Huang C; Zhu Z Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):195-7. PubMed ID: 11243135 [TBL] [Abstract][Full Text] [Related]
8. [Hereditary methemoglobinemia due to NADH cytochrome b5 abnormality--clinical importance of the enzyme in leukocytes and platelets]. Tomita Y; Inagaki M; Taki M; Miura T; Saito N; Meguro T; Yamada K; Fujii H; Takizawa T; Miwa S Rinsho Ketsueki; 1986 Mar; 27(3):412-9. PubMed ID: 3735692 [No Abstract] [Full Text] [Related]
9. Electrostatic properties deduced from refined structures of NADH-cytochrome b5 reductase and the other flavin-dependent reductases: pyridine nucleotide-binding and interaction with an electron-transfer partner. Nishida H; Miki K Proteins; 1996 Sep; 26(1):32-41. PubMed ID: 8880927 [TBL] [Abstract][Full Text] [Related]
10. A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: determination of the molecular basis. Aalfs CM; Salieb-Beugelaar GB; Wanders RJ; Mannens MM; Wijburg FA Hum Mutat; 2000; 16(1):18-22. PubMed ID: 10874300 [TBL] [Abstract][Full Text] [Related]
11. [Genetics and biochemistry of NADH-cytochrome b5 reductase deficiency]. Shirabe K Nihon Rinsho; 1999 Sep; 57 Suppl():769-71. PubMed ID: 10543233 [No Abstract] [Full Text] [Related]
18. Cytochrome b5 reductase deficiency, an uncommon cause of cyanosis. Posthumus MD; van Berkel W Neth J Med; 1994 Apr; 44(4):136-40. PubMed ID: 8196824 [TBL] [Abstract][Full Text] [Related]
19. Localization, biosynthesis, and turnover of NADH-cytochrome b5 reductase, a protein that exists in a membrane-bound and a water-soluble form. Borgese N Prog Clin Biol Res; 1982; 91():479-93. PubMed ID: 7146010 [No Abstract] [Full Text] [Related]
20. The reducing ability of iron chelates by NADH-cytochrome B5 reductase or cytochrome B5 responsible for NADH-supported lipid peroxidation. Miura A; Tampo Y; Yonaha M Biochem Mol Biol Int; 1995 Sep; 37(1):141-50. PubMed ID: 8653076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]